ID   ACHA3_RAT               Reviewed;         499 AA.
AC   P04757;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   02-OCT-2024, entry version 177.
DE   RecName: Full=Neuronal acetylcholine receptor subunit alpha-3;
DE   Flags: Precursor;
GN   Name=Chrna3; Synonyms=Acra3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3753746; DOI=10.1038/319368a0;
RA   Boulter J., Evans K., Goldman D.J., Martin G., Treco D., Heinemann S.F.,
RA   Patrick J.;
RT   "Isolation of a cDNA clone coding for a possible neural nicotinic
RT   acetylcholine receptor alpha-subunit.";
RL   Nature 319:368-374(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2444984; DOI=10.1073/pnas.84.21.7763;
RA   Boulter J., Connolly J.G., Deneris E.S., Goldman D.J., Heinemann S.F.,
RA   Patrick J.;
RT   "Functional expression of two neuronal nicotinic acetylcholine receptors
RT   from cDNA clones identifies a gene family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:7763-7767(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-21.
RC   TISSUE=Liver;
RX   PubMed=8144606; DOI=10.1016/s0021-9258(17)34055-3;
RA   Yang X., McDonough J., Fyodorov D., Morris M., Wang F., Deneris E.S.;
RT   "Characterization of an acetylcholine receptor alpha 3 gene promoter and
RT   its activation by the POU domain factor SCIP/Tst-1.";
RL   J. Biol. Chem. 269:10252-10264(1994).
RN   [4]
RP   SUBUNIT.
RX   PubMed=15609996; DOI=10.1021/bi048918g;
RA   Ellison M., Gao F., Wang H.L., Sine S.M., McIntosh J.M., Olivera B.M.;
RT   "Alpha-conotoxins ImI and ImII target distinct regions of the human alpha7
RT   nicotinic acetylcholine receptor and distinguish human nicotinic receptor
RT   subtypes.";
RL   Biochemistry 43:16019-16026(2004).
RN   [5]
RP   SUBUNIT.
RX   PubMed=15929983; DOI=10.1074/jbc.m504229200;
RA   Dutertre S., Nicke A., Lewis R.J.;
RT   "Beta2 subunit contribution to 4/7 alpha-conotoxin binding to the nicotinic
RT   acetylcholine receptor.";
RL   J. Biol. Chem. 280:30460-30468(2005).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407 AND SER-410, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [7]
RP   INTERACTION WITH UBXN2A, SUBCELLULAR LOCATION, AND UBIQUITINATION.
RX   PubMed=19474315; DOI=10.1523/jneurosci.4723-08.2009;
RA   Rezvani K., Teng Y., Pan Y., Dani J.A., Lindstrom J., Garcia Gras E.A.,
RA   McIntosh J.M., De Biasi M.;
RT   "UBXD4, a UBX-containing protein, regulates the cell surface number and
RT   stability of alpha3-containing nicotinic acetylcholine receptors.";
RL   J. Neurosci. 29:6883-6896(2009).
RN   [8]
RP   IDENTIFICATION IN A COMPLEX WITH STUB1; VCP AND UBXN2A, AND UBIQUITINATION.
RX   PubMed=26265139; DOI=10.1016/j.bcp.2015.08.084;
RA   Teng Y., Rezvani K., De Biasi M.;
RT   "UBXN2A regulates nicotinic receptor degradation by modulating the E3
RT   ligase activity of CHIP.";
RL   Biochem. Pharmacol. 97:518-530(2015).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and leads to
CC       opening of an ion-conducting channel across the plasma membrane.
CC   -!- SUBUNIT: Neuronal AChR is composed of two different types of subunits:
CC       alpha and beta. Alpha-3 subunit can be combined to beta-2 or beta-4 to
CC       give rise to functional receptors. Part of a complex composed of
CC       STUB1/CHIP, VCP/p97, CHRNA3, and UBXN2A that modulates the
CC       ubiquitination and endoplasmic reticulum-associated degradation (ERAD)
CC       of CHRNA3 (PubMed:26265139). Within the complex UBXN2A acts as a
CC       scaffold protein required for the interaction of CHRNA3 with VCP/p97,
CC       this interaction also inhibits CHRNA3 ubiquitination by STUB1/CHIP and
CC       subsequently ERAD (PubMed:26265139). Interacts with UBXN2A (via SEP
CC       domain), the interaction is required for the interaction of CHRNA3 in
CC       the STUB1-VCP-UBXN2A complex (PubMed:19474315). Interacts with RIC3;
CC       which is required for proper folding and assembly. Interacts with
CC       LYPD6. The heteropentamer alpha-3-beta-2 interacts with alpha-
CC       conotoxins ImI, ImII, PnIA, GID and MII (PubMed:15609996,
CC       PubMed:15929983). {ECO:0000250|UniProtKB:P32297,
CC       ECO:0000269|PubMed:15609996, ECO:0000269|PubMed:15929983,
CC       ECO:0000269|PubMed:19474315, ECO:0000269|PubMed:26265139}.
CC   -!- SUBCELLULAR LOCATION: Postsynaptic cell membrane; Multi-pass membrane
CC       protein. Cell membrane {ECO:0000269|PubMed:19474315}; Multi-pass
CC       membrane protein. Endoplasmic reticulum {ECO:0000269|PubMed:19474315}.
CC       Golgi apparatus {ECO:0000269|PubMed:19474315}. Note=Interaction with
CC       UBXN2A/UBXD4 promotes translocation to the plasma membrane.
CC       {ECO:0000269|PubMed:19474315}.
CC   -!- PTM: Ubiquitinated; by STUB1/CHIP and thereafter degraded by the 26S
CC       proteosome complex. {ECO:0000269|PubMed:19474315,
CC       ECO:0000269|PubMed:26265139}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9) family.
CC       Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-3/CHRNA3 sub-
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X03440; CAA27170.1; -; mRNA.
DR   EMBL; L31621; AAA41673.1; -; mRNA.
DR   EMBL; U04961; AAA18001.1; -; Unassigned_DNA.
DR   PIR; A24572; A24572.
DR   PIR; A53733; A53733.
DR   AlphaFoldDB; P04757; -.
DR   SMR; P04757; -.
DR   ComplexPortal; CPX-190; Neuronal nicotinic acetylcholine receptor complex, alpha3-alpha5-beta2.
DR   ComplexPortal; CPX-191; Neuronal nicotinic acetylcholine receptor complex, alpha3-beta2.
DR   ComplexPortal; CPX-203; Neuronal nicotinic acetylcholine receptor complex, alpha3-alpha6-beta2-beta3.
DR   ComplexPortal; CPX-205; Neuronal nicotinic acetylcholine receptor complex, alpha3-beta4.
DR   ComplexPortal; CPX-208; Neuronal nicotinic acetylcholine receptor complex, alpha3-alpha5-beta4.
DR   ComplexPortal; CPX-211; Neuronal nicotinic acetylcholine receptor complex, alpha3-alpha6-beta4.
DR   IntAct; P04757; 3.
DR   STRING; 10116.ENSRNOP00000019307; -.
DR   BindingDB; P04757; -.
DR   ChEMBL; CHEMBL1907587; -.
DR   ChEMBL; CHEMBL1907593; -.
DR   ChEMBL; CHEMBL3137275; -.
DR   ChEMBL; CHEMBL3137276; -.
DR   ChEMBL; CHEMBL4106146; -.
DR   DrugCentral; P04757; -.
DR   GuidetoPHARMACOLOGY; 464; -.
DR   GlyCosmos; P04757; 2 sites, No reported glycans.
DR   GlyGen; P04757; 2 sites.
DR   iPTMnet; P04757; -.
DR   PhosphoSitePlus; P04757; -.
DR   PaxDb; 10116-ENSRNOP00000019307; -.
DR   UCSC; RGD:2345; rat.
DR   AGR; RGD:2345; -.
DR   RGD; 2345; Chrna3.
DR   eggNOG; KOG3645; Eukaryota.
DR   InParanoid; P04757; -.
DR   PhylomeDB; P04757; -.
DR   Reactome; R-RNO-629587; Highly sodium permeable postsynaptic acetylcholine nicotinic receptors.
DR   Reactome; R-RNO-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-RNO-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   PRO; PR:P04757; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:RGD.
DR   GO; GO:0098981; C:cholinergic synapse; IDA:SynGO.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0098691; C:dopaminergic synapse; IDA:SynGO.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0044853; C:plasma membrane raft; IGI:ARUK-UCL.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; IDA:SynGO.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:0042166; F:acetylcholine binding; IDA:RGD.
DR   GO; GO:0015464; F:acetylcholine receptor activity; IDA:RGD.
DR   GO; GO:0022848; F:acetylcholine-gated monoatomic cation-selective channel activity; IMP:RGD.
DR   GO; GO:1901363; F:heterocyclic compound binding; IDA:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:1904315; F:transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0095500; P:acetylcholine receptor signaling pathway; IGI:ARUK-UCL.
DR   GO; GO:0035095; P:behavioral response to nicotine; ISO:RGD.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:0007507; P:heart development; IEP:RGD.
DR   GO; GO:0007626; P:locomotory behavior; ISO:RGD.
DR   GO; GO:0051899; P:membrane depolarization; IBA:GO_Central.
DR   GO; GO:0007399; P:nervous system development; ISO:RGD.
DR   GO; GO:0099171; P:presynaptic modulation of chemical synaptic transmission; IDA:SynGO.
DR   GO; GO:0014056; P:regulation of acetylcholine secretion, neurotransmission; ISO:RGD.
DR   GO; GO:0048814; P:regulation of dendrite morphogenesis; ISO:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0006937; P:regulation of muscle contraction; ISO:RGD.
DR   GO; GO:0006940; P:regulation of smooth muscle contraction; ISO:RGD.
DR   GO; GO:1905144; P:response to acetylcholine; IGI:ARUK-UCL.
DR   GO; GO:0034465; P:response to carbon monoxide; IEP:RGD.
DR   GO; GO:0035094; P:response to nicotine; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IDA:RGD.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0060084; P:synaptic transmission involved in micturition; ISO:RGD.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; ISO:RGD.
DR   CDD; cd19016; LGIC_ECD_nAChR_A3; 1.
DR   CDD; cd19064; LGIC_TM_nAChR; 1.
DR   Gene3D; 2.70.170.10; Neurotransmitter-gated ion-channel ligand-binding domain; 1.
DR   Gene3D; 1.20.58.390; Neurotransmitter-gated ion-channel transmembrane domain; 2.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR038050; Neuro_actylchol_rec.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   NCBIfam; TIGR00860; LIC; 1.
DR   PANTHER; PTHR18945:SF831; NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT ALPHA-3; 1.
DR   PANTHER; PTHR18945; NEUROTRANSMITTER GATED ION CHANNEL; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF90112; Neurotransmitter-gated ion-channel transmembrane pore; 1.
DR   SUPFAM; SSF63712; Nicotinic receptor ligand binding domain-like; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disulfide bond; Endoplasmic reticulum; Glycoprotein;
KW   Golgi apparatus; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Phosphoprotein; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane; Transmembrane helix;
KW   Transport; Ubl conjugation.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   CHAIN           26..499
FT                   /note="Neuronal acetylcholine receptor subunit alpha-3"
FT                   /id="PRO_0000000348"
FT   TOPO_DOM        26..234
FT                   /note="Extracellular"
FT   TRANSMEM        235..259
FT                   /note="Helical"
FT   TRANSMEM        267..285
FT                   /note="Helical"
FT   TRANSMEM        301..322
FT                   /note="Helical"
FT   TOPO_DOM        323..471
FT                   /note="Cytoplasmic"
FT   TRANSMEM        472..491
FT                   /note="Helical"
FT   MOD_RES         407
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         410
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   CARBOHYD        49
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        166
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        153..167
FT                   /evidence="ECO:0000250"
FT   DISULFID        217..218
FT                   /note="Associated with receptor activation"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   499 AA;  56998 MW;  D66C491E832B9C34 CRC64;
     MGVVLLPPPL SMLMLVLMLL PAASASEAEH RLFQYLFEDY NEIIRPVANV SHPVIIQFEV
     SMSQLVKVDE VNQIMETNLW LKQIWNDYKL KWKPSDYQGV EFMRVPAEKI WKPDIVLYNN
     ADGDFQVDDK TKALLKYTGE VTWIPPAIFK SSCKIDVTYF PFDYQNCTMK FGSWSYDKAK
     IDLVLIGSSM NLKDYWESGE WAIIKAPGYK HEIKYNCCEE IYQDITYSLY IRRLPLFYTI
     NLIIPCLLIS FLTVLVFYLP SDCGEKVTLC ISVLLSLTVF LLVITETIPS TSLVIPLIGE
     YLLFTMIFVT LSIVITVFVL NVHYRTPTTH TMPTWVKAVF LNLLPRVMFM TRPTSGEGDT
     PKTRTFYGAE LSNLNCFSRA DSKSCKEGYP CQDGTCGYCH HRRVKISNFS ANLTRSSSSE
     SVNAVLSLSA LSPEIKEAIQ SVKYIAENMK AQNVAKEIQD DWKYVAMVID RIFLWVFILV
     CILGTAGLFL QPLMARDDT
//
